STAR CAPITAL takes majority stake in Glenholme Specialist Care

Alongside founder and Chief Executive Officer Don Serratt, who maintains a significant leadership position and equity stake, the private equity firm STAR Capital Partnership formally executes the acquisition of the Glenholme Specialist Care division. Officially announced on June 2, 2026, this multijurisdictional corporate carve-out successfully separates the specialized disability care unit from its former parent entity, the Glenholme Healthcare Group. To execute this complex transactional mandate, the acquiring financial sponsor deployed dedicated institutional capital directly from its STAR IV Fund, deliberately securing majority ownership of the clinical operating platform. While the definitive financial terms and exact valuation metrics governing the buyout remain strictly undisclosed, the strategic architecture of the deal perfectly aligns with the acquiring firm's core investment thesis centered on backing highly regulated, essential social infrastructure. By internalizing this specific healthcare asset, the new controlling shareholder captures a highly resilient platform characterized by robust placement stability mandated by United Kingdom statutory obligations. The institutional capital injection is strategically engineered to finance the continuous in-house development of new residential services, enabling the clinical management team to rapidly expand their geographic footprint and address surging, uncorrelated demand within the domestic social care sector. To ensure rigorous clinical governance and guide the platform's accelerated expansion phase, the acquiring consortium actively recruited Mel Ramsey, a highly experienced former chief executive of several domestic care businesses, to serve as the newly appointed Chair of the Board. For the selling parent organization, this strategic divestiture represents a successful monetization of its specialized care division, allowing for a structured corporate separation. To orchestrate the competitive financial auction and navigate the complex carve-out dynamics, the parent group exclusively mandated the investment banking firm Baird to serve as its sole financial advisor. Ultimately, this leveraged buyout, championed by partner Mark Coxall at the acquiring fund, successfully transitions a premier statutory healthcare provider into an independent, sponsor-backed infrastructure platform primed for scaled institutional growth.